期刊文献+

新生儿常用药物治疗 被引量:5

暂未订购
导出
摘要 由于新生儿机体发育未成熟及药物动力学的特殊性,新生儿用药有许多特殊要求,临床用药的选用面临许多限制和困难。本文主要介绍新生儿抗感染药物、呼吸系统、心血管系统、神经系统等药物的应用指征、应用方法、不良反应及注意事项,并介绍一些新药的新进展。综合性医院的儿科医师应了解新生儿用药的特殊性,正确掌握这些药物的临床使用。
作者 陈超
出处 《世界临床药物》 CAS 2004年第6期341-345,共5页 World Clinical Drug
  • 相关文献

参考文献8

  • 1Comer AM;Perry CM;Figgitt DP.Caffeine citrate: a review of its use in apnea of prematurity[J],2001(01).
  • 2Lee TC;Charles B;Steer P.Population pharmacokinetics of intravenous caffeine in apnea of prematurity,1997(06).
  • 3Bhatia J.Current option in the management of apnea of prematurity[J],2000(06).
  • 4Makhoul IR;Kassis I;Smolkin T.Review of 49 neonates with acquired fungal sepsis:further characterization[J],2001(01).
  • 5朱德妹,熊自忠,汪复,胡付品,吴湜.超广谱β-内酰胺酶和细菌耐药性[J].中华传染病杂志,2000,18(3):151-154. 被引量:133
  • 6GRIMSLEY C;Thomson AT.Pharmacokinetics and dose requirements of vancomycin in neonates,1999(03).
  • 7Fujiu T;Maruyama K;Koizumi T.Early-onset Group B streptococcal sepsis in a preterm infant with Kostmann syndrome[J],2002(12).
  • 8钟雁,吴明昌,佟月娟,申阿东,杨永弘.新生儿B组链球菌感染性疾病的研究[J].中华围产医学杂志,2002,5(1):38-41. 被引量:9

二级参考文献12

  • 1杨永弘,朱荫芝.B族链球菌感染的研究进展[J].北京医学,1997,19(3):169-171. 被引量:9
  • 2Xuzhuang Shen, Yonghong Yang, Jinhua Zhang, et al. Prevalence of antibodies a gainst group B streptococcal capsular polysaccharides in healthy Chinese neonate s. J Pediatr Infect Dis, 1997,16:1179-1180.
  • 3Kenneth M, Boyer MD,Samnel P, et al. Alternative algorithms for prevention of perinatal group B streptococcal infections. J Pediatr Infect Dis,1998,17: 973-979.
  • 4Siegel JD, Cushion NB. Prevention of early-onset group B streptococcal disea se: another look at single-dose penicillin at birth[J]. Obstetrics Gynecol, 1996,87:692-698.
  • 5Centers for Disease Control and Prevention. Prevention of perinatal group B s treptococcal disease : a public health perspective. MMWR,1996,45(RR-7):1-24.
  • 6Siro D.Extended-spectrumβ-lactamases[].Journal of Antimicrobial Chemotherapy.1995
  • 7Philippon A,Labia R,Jacoby G.Extended-spectrum beta-lactamases[].Antimicrobial Agents and Chemotherapy.1989
  • 8Jacoby GA,Medeiros AA.More extended-spectrum beta-lactamases[].Antimicrobial Agents and Chemotherapy.1991
  • 9NCCLS.Performance standards for antimicrobial susceptibility testing[].Ninth informational supplement.1999
  • 10Sanders CC,Barry AL,Washington JA,et al.Detection of extended-spectrum beta-lactamases producing members of family Enterobacteriaceae with the vitek ESBL test[].Journal of Clinical Microbiology.1996

共引文献139

同被引文献28

  • 1袁琳,陈超.新生儿期使用糖皮质激素的不良反应及使用规范[J].世界临床药物,2005,26(6):348-351. 被引量:6
  • 2培菲康防治婴幼儿肺炎继发腹泻协作组.培菲康预防婴幼儿肺炎继发腹泻随机、多中心临床研究[J].临床儿科杂志,2006,24(10):848-849. 被引量:34
  • 3李雄彪,马庆英,崔云龙.丁酸和叶酸预防与治疗肠道疾病及其分子基础[J].世界华人消化杂志,2006,14(32):3071-3080. 被引量:54
  • 4Wistrom J, Norrby SR, Myhre EB, et al. Frequency of anti- biotic-associated diarrhea in 2462 antibiotic treated hospitalized patients:a prospective study[J].J Antimicrob Chemother,2001,47(4) :43-50.
  • 5Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children[J]. J Pediatr, 1999,135 (5) : 564-568.
  • 6Mcfarland LV. Epidemiology, risk factors and treatment for antibiotic associated diarrhea[J]. Dig Dis, 1998,16 (5) : 292- 307.
  • 7Hogenauer C, Hammer HF,Krejs GJ,et al. Mechanisms and management of antibiotic-associated diarrhea[J]. Clin Infect Dis,1998,27 (4) :702-710.
  • 8D'Souza AL, Rajkumar C, Cooke J, et al. Probiotics in prevention of antibiotic associated diarrhea: meta-analysis[J]. BMJ, 2002,324 (7354) : 1361-1364.
  • 9Tankanov RM, Ross MB, Ertel IJ, et al. Double blind, placebo-controlled study of the efficacy of Laetinex in the prophylaxis of amoxicillin-indueed diarrhea[J]. DICP Ann Pharm, 1990,24:382-384.
  • 10Singh-Naz,N,Sprague BM,Patel KM,et al.Risk assessmem and standardizednosocomial infection rate in critically ill children[J].Urit Med 2000,28(6):2069~75.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部